StockTipsArenaBeta

BUY Concord Biotech Limited — Raja Venkatraman

BUYConcord Biotech Limited
Concord Biotech share price target & all analyst calls

byRaja VenkatramanHorizon: 1–3 months30 Jul 2026via LiveMint Buy-or-Sell (topic)

Entry₹1,335Stated
Target₹1,460
Total upside +9.36% (call closed)
Stop loss₹1,290-3.37% risk
Exit₹1,4604 Aug 2026, 12:08 pm
Target hit+9.36%0.00%upside left
Follow Raja Venkatraman for new calls(23% target hit, 56 closed calls)Get alertsWatch CONCORDBIO for new buy/sell callsGet alertsSee 32 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 4 Aug 2026
0 supporting1 neutral0 opposing
Supports the BUY call (0)

Nothing found in this tip’s window yet.

Neutral / worth noting (1)

Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·31 Jul · 3d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Concord Biotech

All analyst calls on Concord Biotech

More from Raja Venkatraman

Every call and its outcome